Related Experiment Video
Updated: Oct 25, 2025

07:41
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
2.6K
Is There One Key Step in the Metastatic Cascade?
Antoine M Dujon1,2, Jean-Pascal Capp3, Joel S Brown4
1CREEC/CANECEV, MIVEGEC (CREES), University of Montpellier, CNRS, IRD, 34172 Montpellier, France.
Cancers
|August 7, 2021
Summary
Metastases cause most cancer deaths. Our study reveals that the survival of circulating tumor cells (CTCs) is the most critical factor in the metastatic cascade, impacting patient outcomes.
Area of Science:
- Oncology
- Mathematical Biology
- Cancer Metastasis Research
Background:
- Metastasis, the spread of cancer cells, is the primary cause of cancer-related mortality.
- The multi-step process of metastasis, known as the metastatic cascade, is not fully understood.
- Identifying critical steps in metastasis is crucial for understanding patient prognosis.
Purpose of the Study:
- To identify the most critical step in the metastatic cascade that influences the probability of metastasis development.
- To quantify the contribution of each stage of the metastatic cascade to overall metastasis formation.
Main Methods:
- Utilized a modified Drake equation, originally from astrophysics, to model the metastatic cascade.
- Employed simulations with literature-derived parameter values specific to breast cancer.
- Analyzed the linear progression hypothesis of cancer metastasis.
Main Results:
- Simulations identified the survival duration of circulating tumor cells (CTCs) as the paramount parameter.
- The survival of CTCs disproportionately affects the likelihood of clinical metastasis formation.
- Other steps in the cascade have lesser, though still relevant, impacts.
Conclusions:
- The survival of circulating tumor cells is the bottleneck in the metastatic cascade.
- Targeting CTC survival could be a key therapeutic strategy to prevent metastasis.
- This modeling approach provides a novel framework for understanding cancer progression.
Related Concept Videos
Metastasis
5.9K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.9K
Tumor Progression
6.7K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.7K
MAPK Signaling Cascades
6.6K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.6K

